MyJournals Home  

RSS Feeds[ASAP] Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins (Molecular Pharmaceutics)

 
 

16 july 2019 01:00:45

 
[ASAP] Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins (Molecular Pharmaceutics)
 


Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.9b00418


 
228 viewsCategory: Pharmacology
 
Multimodal Analysis of FDA Drug Safety Communications: Lessons from Zolpidem (Drug Safety)
[ASAP] Molecular Computations of Preferential Interaction Coefficients of IgG1 Monoclonal Antibodies with Sorbitol, Sucrose, and Trehalose and the Impact of These Excipients on Aggregation and Viscosity (Molecular Pharmaceutics)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pharmacology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten